资源分配:治疗后稳定的患者12-24小时内仍保持稳定
本研究前瞻性随访2016-2018年在本机构接受静脉tPA和/或机械取栓的急性缺血性卒中患者172例(单纯静脉135例、动脉65例、两者均用30例),按方案每15分钟检查2小时、每30分钟检查6小时、之后每小时检查至24小时。结果36例(21%)记录到神经功能恶化,其中8例(4.7%)为脑出血;仅5例在12-24小时窗口恶化,且其中4例此前已有检查异常。作者结论认为治疗后12-24小时新发神经功能恶化罕见,低NIHSS且无ICU需求的稳定患者可能无需超过12小时的密集监护。
要点
- 172例接受静脉tPA和/或取栓的急性缺血性卒中患者中,36例(21%)记录到神经功能恶化,其中8例(4.7%)为脑出血。
- 仅5例在治疗后12-24小时窗口发生神经功能恶化,且其中4例此前已有检查变化。
- 基线NIHSS升高与总体神经功能恶化风险升高相关;早期波动与12小时后恶化相关。
- 作者认为低NIHSS且无ICU需求的稳定患者可能无需超过12小时的密集监护。
适用人群与场景
- 2016-2018年在本机构接受静脉tPA和/或机械取栓治疗的急性缺血性卒中患者,共172例(单纯静脉135例、动脉65例、两者均用30例)。
处置流程与药物剂量
- 治疗后24小时内按方案监测:每15分钟检查一次共2小时,每30分钟检查一次共6小时,之后每小时检查一次直至24小时。
红旗征与不能漏的情况
- 神经功能恶化共36例(21%),其中8例(4.7%)由脑出血导致。
- 12-24小时窗口恶化的5例中,4例此前已有检查变化;早期波动与12小时后恶化相关。
- 基线NIHSS升高与总体神经功能恶化风险升高相关。
研究设计与关键结果
- 前瞻性按方案随访研究,纳入2016-2018年本机构接受静脉tPA和/或取栓的急性缺血性卒中患者172例(单纯静脉135例、动脉65例、两者均用30例)。
- 36例(21%)记录到神经功能恶化,其中8例(4.7%)为脑出血。
- 12-24小时窗口内仅5例恶化,其中4例此前已有检查变化。
- 基线NIHSS升高与总体神经功能恶化风险升高相关;早期波动与12小时后恶化相关。
证据类型、等级与局限
- 证据类型:前瞻性按方案随访研究。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者认为,低NIHSS评分且无ICU需求的稳定患者在治疗后可能无需超过12小时的密集监护。
- 早期出现检查波动的患者与12小时后恶化相关,提示此类患者需继续关注。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
BACKGROUND AND PURPOSE: Stroke patients are currently monitored for neurological deterioration for 24 h following treatment with intravenous tissue plasminogen activator (IV tPA) or mechanical thrombectomy. This requires low nursing ratios and an intensive-care-like setting. As the half-life of IV tPA is short, many patients may not require such prolonged intensive monitoring and could be downgraded much earlier. We evaluate the frequency of neurological deterioration in the 0-12 and 12-24 h post-treatment windows.
METHODS: Patients presenting with acute ischemic stroke treated with IV tPA and/or thrombectomy at our institution from 2016-2018 were prospectively followed per protocol for 24 h post-therapy (examinations every 15 min for 2 h, every 30 min for 6 h, and hourly thereafter). Neurological deteriorations were recorded along with interventions and complications. Frequency of deterioration within the 0-12 and 12-24 h post-treatment windows was determined, along with factors associated with decline at each time point.
RESULTS: A total of 172 patients were treated (IV:135, IA:65, both:30). Thirty-six (21%) experienced a documented neurologic deterioration [8 due to intracerebral hemorrhage (4.7%)]. Five patients deteriorated in the 12-24 h window; all but one had experienced earlier examination changes. Elevated NIHSS was associated with a higher likelihood of deterioration overall. Early fluctuation was associated with decline after 12 h.
CONCLUSIONS: New onset of neurologic deterioration is rare 12-24 h after treatment of acute stroke. Stable patients with low NIHSS scores and no ICU needs may not require intensive monitoring greater than 12 h post-treatment.
参考来源
- Khan S, Soto A, Marsh EB, et al. Resource Allocation: Stable Patients Remain Stable 12-24 h Post-tPA. Neurocrit Care. 2020. PMID: 31820292. doi:10.1007/s12028-019-00889-z
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。